Genetic diseases
In this section you will find Therapeutics Diseases & Conditions Genetic diseases market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
3 Item(s)
per page
-
Global Multiple Sclerosis Drug Market 2010-2025
€1,739.00Published by Visiongain on Mar 3rd, 2010The multiple sclerosis (MS) treatments market is one of the largest for CNS disorders, with total pharmaceutical revenues of over $8bn in 2009. Revenues for MS treatments will rise significantly... Learn More -
The Global Multiple Sclerosis Market 2009-2024
€1,739.00Published by Visiongain on Mar 19th, 2009The multiple sclerosis (MS) market has total global revenues of over $6bn in 2008. Those revenues will exceed $9bn during the second half of next decade, our new study shows. This report will provide you with the analytical information that you need to understand current trends and future directions in the MS market area, the successful drugs being introduced and where the future successful growth of the market lies. Learn More -
Multiple Sclerosis Market Analysis & Forecasts Report 2007-2022
€1,739.00Published by Visiongain on Aug 2nd, 2007The World Health Organization (WHO) estimates that over 2.5 million people globally suffer from Multiple Sclerosis (MS). With the present global population growing to an unprecedented height of 6.5 billion in 2005 and growth rate anticipated to reach 7.6 billion by 2020, the prevalence and onset of MS in children and particularly adults is expected to rise exponentially. Learn More
3 Item(s)
per page